Viatris Inc.
General ticker "VTRS" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $11.8B (TTM average)
Viatris Inc. follows the US Stock Market performance with the rate: 58.3%.
Estimated limits based on current volatility of 2.0%: low 14.46$, high 15.03$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-11-24, amount 0.12$ (Y3.30%)
- Total employees count: 32000 as of 2024
- China accounted for 13.3% of revenue in the fiscal year ended 2024-12-31
- US accounted for 23.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on key products, Regulatory and compliance, Supply chain disruptions, Currency fluctuations, Strategic risks and growth management
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [10.33$, 16.22$]
- 2026-12-31 to 2027-12-31 estimated range: [10.18$, 16.20$]
Financial Metrics affecting the VTRS estimates:
- Positive: with PPE of 5.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 16.28 > 12.96
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0.73 <= 0.80
- Positive: 19.40 < Shareholder equity ratio, % of 39.55 <= 42.68
Short-term VTRS quotes
Relationship graph
Long-term VTRS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $15,315.30MM | $14,388.40MM | $14,299.90MM |
| Operating Expenses | $14,549.10MM | $14,378.30MM | $16,963.00MM |
| Operating Income | $766.20MM | $10.10MM | $-2,663.10MM |
| Non-Operating Income | $-563.30MM | $-633.30MM | $-1,001.90MM |
| Interest Expense | $573.10MM | $550.00MM | $471.30MM |
| R&D Expense | $910.70MM | $837.00MM | $965.90MM |
| Income(Loss) | $202.90MM | $-623.20MM | $-3,665.00MM |
| Taxes | $148.20MM | $11.00MM | $-150.10MM |
| Profit(Loss)* | $54.70MM | $-634.20MM | $-3,514.90MM |
| Stockholders Equity | $20,467.40MM | $18,635.50MM | $14,711.30MM |
| Inventory | $3,469.70MM | $3,854.10MM | $3,999.20MM |
| Assets | $47,685.50MM | $41,500.90MM | $37,193.10MM |
| Operating Cash Flow | $2,900.00MM | $2,302.90MM | $2,315.90MM |
| Capital expenditure | $474.50MM | $326.00MM | $378.80MM |
| Investing Cash Flow | $-864.50MM | $1,800.70MM | $-427.70MM |
| Financing Cash Flow | $-2,301.90MM | $-4,330.40MM | $-1,293.90MM |
| Earnings Per Share** | $0.05 | $-0.53 | $-3.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.